Black men have lower preference for investigation of prostate cancer
the ONA take:
According to a recent study published in the British Journal of General Practice, researchers from University of Exeter Medical School in Exeter, United Kingdom, have found that black men are less willing to be investigated for prostate cancer, thereby increasing the likelihood of being diagnosed as emergencies and having a higher mortality rate compared with white men.
For the study, researchers identified over 500 men attending general practices in Bristol, United Kingdom, and presented them with realistic hypothetical scenarios in which the participants was given a description of a prostate cancer symptom and the estimated risk of prostate cancer.
Results showed that black men were less likely to prefer investigation of the symptom despite the risk given in the scenario. Researchers found that when participants were presented with scenarios associated with the lowest risk level, only 44% of black males opted for investigation versus 91% of white males.
Among both groups, the most common reason for choosing not to investigate the symptom was low risk, but significantly more black participants reported that they did not want to know if they had cancer.
The findings suggest that health care professionals should proactively discuss the subject of cancer with their patients and education targeted at the black community may help reduce fear of cancer investigation.
Black men are less willing to be investigated for prostate cancer, thereby increasing the likelihood of being diagnosed.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|